The report on Artificial Hearts and Circulatory Assist market offers an overview of several major countries spread across various geographic regions over the globe. The report concentrates on recognizing various market developments, dynamics, growth drivers and factors hampering the market growth. Further, the report delivers comprehensive insights into numerous growth opportunities and challenges based on various types of products, applications, end users and countries, among others.

Key Market Players
According to the global Artificial Hearts and Circulatory Assist market analysis, the key players operating include

Medtronic PLC
Abbott Laboratories
ABIOMED
LivaNova PLC
Berlin Heart
BiVACOR
CARMAT
Jarvik Heart Inc
SynCardia Systems
Yongrenxin Medical

Report Scope:
A complete interpretation of the global Artificial Hearts and Circulatory Assist market

Attractive investment plans in the global Artificial Hearts and Circulatory Assist market based on various segments such as product type, application, end user etc.
Important success factors and pain points in the form of growth drivers and restraints leading the market outlook along with future trend examination
In depth company profiles offering insights into their product offerings, strategies, revenue information and latest market activities
Information on industry value chain analysis of the global Artificial Hearts and Circulatory Assist market providing an analytical study of key stakeholders involved, which could advance market participants in formulating appropriate strategies
Competitive landscape of the global Artificial Hearts and Circulatory Assist market and market share analysis based on company’s performance and customer reach

Report Overview:
This study was conducted with a global viewpoint in terms of the various segments in the Artificial Hearts and Circulatory Assist market. Market sizing and estimate have been conducted for 5 geographic regions: North America, Latin America, Europe, Middle East and Africa (MEA), and Asia-Pacific. All market sizing information is delivered in US$ with historic data for 2018 and 2019, along with valuations and forecast for the period from 2020 to 2028.
Apart from that, the report also provides important distinguishing information regarding each of the market segments. These segments are analyses further on different fronts such as historical performance, market size contributions, % market share, expected rate of growth.

COVID-19 Impact:
The report provides how this industry is likely to be impacted as a result of the global COVID-19 pandemic. Market value by revenue is expected to develop xx% in 2020 alone as demand is expected to be reasonably affected by the outbreak of COVID-19. The downstream companies contend with limited profit from falling consumer confidence, demand for industry products is expected to slow. Demand from top notch companies and government agencies is expected to grow as they seek more data on COVID-19. Almost, every sector is anticipated to be impacted by COVID-19 pandemic. Some of the industries are struggling and some are thriving.

Key Market Segmentation:
Artificial Hearts and Circulatory Assist Market, by Type:

Ventricular Assist Devices
Artificial Heart

Artificial Hearts and Circulatory Assist Market, by Application:

Coronary Heart Disease
Cerebrovascular Disease
Peripheral Arterial Disease
Rheumatic Heart Disease
Congenital Heart Disease
Deep Vein Thrombosis
Other

Artificial Hearts and Circulatory Assist Market, by Geography:
On the basis of region, the global Artificial Hearts and Circulatory Assist market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regional segmentation consists of the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

North America
- U.S.
- Canada
Europe
- UK
- Germany
- France
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East and Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

1 Artificial Hearts and Circulatory Assist Market Overview
1.1 Product Overview and Scope of Artificial Hearts and Circulatory Assist
1.2 Artificial Hearts and Circulatory Assist Segment by Type
1.2.1 Global Artificial Hearts and Circulatory Assist Sales Growth Rate Comparison by Type (2020-2026)
1.2.2 Ventricular Assist Devices
1.2.3 Artificial Heart
1.3 Artificial Hearts and Circulatory Assist Segment by Application
1.3.1 Artificial Hearts and Circulatory Assist Sales Comparison by Application: (2020-2026)
1.3.2 Coronary Heart Disease
1.3.3 Cerebrovascular Disease
1.3.4 Peripheral Arterial Disease
1.3.5 Rheumatic Heart Disease
1.3.6 Congenital Heart Disease
1.3.7 Deep Vein Thrombosis
1.3.8 Other
1.4 Global Artificial Hearts and Circulatory Assist Market Size Estimates and Forecasts
1.4.1 Global Artificial Hearts and Circulatory Assist Revenue 2015-2026
1.4.2 Global Artificial Hearts and Circulatory Assist Sales 2015-2026
1.4.3 Artificial Hearts and Circulatory Assist Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19): Artificial Hearts and Circulatory Assist Industry Impact
1.5.1 How the Covid-19 is Affecting the Artificial Hearts and Circulatory Assist Industry
1.5.1.1 Artificial Hearts and Circulatory Assist Business Impact Assessment - Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Artificial Hearts and Circulatory Assist Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures/Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Artificial Hearts and Circulatory Assist Players to Combat Covid-19 Impact
1.6 Study Objectives
1.7 Years Considered

2 Global Artificial Hearts and Circulatory Assist Market Competition by Manufacturers
2.1 Global Artificial Hearts and Circulatory Assist Sales Market Share by Manufacturers (2015-2020)
2.2 Global Artificial Hearts and Circulatory Assist Revenue Share by Manufacturers (2015-2020)
2.3 Global Artificial Hearts and Circulatory Assist Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Artificial Hearts and Circulatory Assist Manufacturing Sites, Area Served, Product Type
2.5 Artificial Hearts and Circulatory Assist Market Competitive Situation and Trends
2.5.1 Artificial Hearts and Circulatory Assist Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Artificial Hearts and Circulatory Assist Players (Opinion Leaders)

3 Artificial Hearts and Circulatory Assist Retrospective Market Scenario by Region
3.1 Global Artificial Hearts and Circulatory Assist Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Artificial Hearts and Circulatory Assist Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Artificial Hearts and Circulatory Assist Market Facts & Figures by Country
3.3.1 North America Artificial Hearts and Circulatory Assist Sales by Country
3.3.2 North America Artificial Hearts and Circulatory Assist Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Artificial Hearts and Circulatory Assist Market Facts & Figures by Country
3.4.1 Europe Artificial Hearts and Circulatory Assist Sales by Country
3.4.2 Europe Artificial Hearts and Circulatory Assist Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Artificial Hearts and Circulatory Assist Market Facts & Figures by Region
3.5.1 Asia Pacific Artificial Hearts and Circulatory Assist Sales by Region
3.5.2 Asia Pacific Artificial Hearts and Circulatory Assist Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Artificial Hearts and Circulatory Assist Market Facts & Figures by Country
3.6.1 Latin America Artificial Hearts and Circulatory Assist Sales by Country
3.6.2 Latin America Artificial Hearts and Circulatory Assist Sales by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Artificial Hearts and Circulatory Assist Market Facts & Figures by Country
3.7.1 Middle East and Africa Artificial Hearts and Circulatory Assist Sales by Country
3.7.2 Middle East and Africa Artificial Hearts and Circulatory Assist Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Artificial Hearts and Circulatory Assist Historic Market Analysis by Type
4.1 Global Artificial Hearts and Circulatory Assist Sales Market Share by Type (2015-2020)
4.2 Global Artificial Hearts and Circulatory Assist Revenue Market Share by Type (2015-2020)
4.3 Global Artificial Hearts and Circulatory Assist Price Market Share by Type (2015-2020)
4.4 Global Artificial Hearts and Circulatory Assist Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Artificial Hearts and Circulatory Assist Historic Market Analysis by Application
5.1 Global Artificial Hearts and Circulatory Assist Sales Market Share by Application (2015-2020)
5.2 Global Artificial Hearts and Circulatory Assist Revenue Market Share by Application (2015-2020)
5.3 Global Artificial Hearts and Circulatory Assist Price by Application (2015-2020)

6 Company Profiles and Key Figures in Artificial Hearts and Circulatory Assist Business
6.1 Medtronic PLC
6.1.1 Corporation Information
6.1.2 Medtronic PLC Description, Business Overview
6.1.3 Medtronic PLC Artificial Hearts and Circulatory Assist Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Medtronic PLC Products Offered
6.1.5 Medtronic PLC Recent Development
6.2 Abbott Laboratories
6.2.1 Corporation Information
6.2.2 Abbott Laboratories Description, Business Overview
6.2.3 Abbott Laboratories Artificial Hearts and Circulatory Assist Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Abbott Laboratories Products Offered
6.2.5 Abbott Laboratories Recent Development
6.3 ABIOMED
6.3.1 Corporation Information
6.3.2 ABIOMED Description, Business Overview
6.3.3 ABIOMED Artificial Hearts and Circulatory Assist Sales, Revenue and Gross Margin (2015-2020)
6.3.4 ABIOMED Products Offered
6.3.5 ABIOMED Recent Development
6.4 LivaNova PLC
6.4.1 Corporation Information
6.4.2 LivaNova PLC Description, Business Overview
6.4.3 LivaNova PLC Artificial Hearts and Circulatory Assist Sales, Revenue and Gross Margin (2015-2020)
6.4.4 LivaNova PLC Products Offered
6.4.5 LivaNova PLC Recent Development
6.5 Berlin Heart
6.5.1 Corporation Information
6.5.2 Berlin Heart Description, Business Overview
6.5.3 Berlin Heart Artificial Hearts and Circulatory Assist Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Berlin Heart Products Offered
6.5.5 Berlin Heart Recent Development
6.6 BiVACOR
6.6.1 Corporation Information
6.6.2 BiVACOR Description, Business Overview
6.6.3 BiVACOR Artificial Hearts and Circulatory Assist Sales, Revenue and Gross Margin (2015-2020)
6.6.4 BiVACOR Products Offered
6.6.5 BiVACOR Recent Development
6.7 CARMAT
6.7.1 Corporation Information
6.7.2 CARMAT Description, Business Overview
6.7.3 CARMAT Artificial Hearts and Circulatory Assist Sales, Revenue and Gross Margin (2015-2020)
6.7.4 CARMAT Products Offered
6.7.5 CARMAT Recent Development
6.8 Jarvik Heart Inc
6.8.1 Corporation Information
6.8.2 Jarvik Heart Inc Description, Business Overview
6.8.3 Jarvik Heart Inc Artificial Hearts and Circulatory Assist Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Jarvik Heart Inc Products Offered
6.8.5 Jarvik Heart Inc Recent Development
6.9 SynCardia Systems
6.9.1 Corporation Information
6.9.2 SynCardia Systems Description, Business Overview
6.9.3 SynCardia Systems Artificial Hearts and Circulatory Assist Sales, Revenue and Gross Margin (2015-2020)
6.9.4 SynCardia Systems Products Offered
6.9.5 SynCardia Systems Recent Development

7 Artificial Hearts and Circulatory Assist Manufacturing Cost Analysis
7.1 Artificial Hearts and Circulatory Assist Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Artificial Hearts and Circulatory Assist
7.4 Artificial Hearts and Circulatory Assist Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Artificial Hearts and Circulatory Assist Distributors List
8.3 Artificial Hearts and Circulatory Assist Customers

9 Market Dynamics
9.1 Market Overview
9.2 Market Trends
9.3 Market Inclination Insights Analysis
9.4 Drivers
9.5 Opportunities
9.6 Challenges
9.7 Future Prospects
9.8 Impact Analysis of Drivers and Challenges During the Forecast Period, (2018-2028)

10 Global Market Forecast
10.1 Global Artificial Hearts and Circulatory Assist Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Artificial Hearts and Circulatory Assist by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Artificial Hearts and Circulatory Assist by Type (2021-2026)
10.2 Artificial Hearts and Circulatory Assist Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Artificial Hearts and Circulatory Assist by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Artificial Hearts and Circulatory Assist by Application (2021-2026)
10.3 Artificial Hearts and Circulatory Assist Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Artificial Hearts and Circulatory Assist by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Artificial Hearts and Circulatory Assist by Region (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

3045

Client base spread across 100+ countries - including 20% of Fortune 500 companies and 3000+ SMEs
4 Million+ Hours of Research Experience including 350+ Client Queries Handled Each Day
Incisive Insights into Market Dynamics – 2 Million+ Data Points, 1.2 Mn+ New Data Points Captured Each Year
Deeper Study, Minimal Assumptions – Years of Expertise and Diligence Incorporated

3045

Client base spread across 100+ countries - including 20% of Fortune 500 companies and 3000+ SMEs
4 Million+ Hours of Research Experience including 350+ Client Queries Handled Each Day
Incisive Insights into Market Dynamics – 2 Million+ Data Points, 1.2 Mn+ New Data Points Captured Each Year
Deeper Study, Minimal Assumptions – Years of Expertise and Diligence Incorporated

3045

Client base spread across 100+ countries - including 20% of Fortune 500 companies and 3000+ SMEs
4 Million+ Hours of Research Experience including 350+ Client Queries Handled Each Day
Incisive Insights into Market Dynamics – 2 Million+ Data Points, 1.2 Mn+ New Data Points Captured Each Year
Deeper Study, Minimal Assumptions – Years of Expertise and Diligence Incorporated

Our Research Methodology is based on the following main points:

Data Collections and Interpretation
Analysis
Data Validation
Final Projections and Conclusion

SELECT USER FORMAT

Single User: It allows one person, the buyer, to have sole right and access to the purchased report. Further distribution of product is strictly prohibited.
$2350
Multi User : It allows the purchased product to be shared among 5 people within your organization at maximum.
$3350
Corporate User : It allows the purchased product to be shared among all employees of your organization irrespective of their geographical location.
$4350

Why Zeal Insider?

Inflallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time of readers

Global Artificial Hearts and Circulatory Assist Market By Product Type (Ventricular Assist Devices, Artificial Heart) And By End-Users/Application (Coronary Heart Disease, Cerebrovascular Disease) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

SELECT USER FORMAT

Why Zeal Insider?

Inflallible Methodology

Analyst Support

Customization

Targeted Market View

OUR CLIENT

About Company

Need Help

Contact Us

About Us